Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Neurochem Res ; 45(11): 2762-2774, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32918662

RESUMEN

Noise has always been an important environmental factor that induces health problems in the general population. Due to ever increasing noise pollution, humans are facing multiple auditory and non-auditory problems including neuropsychiatric disorders. In modern day life it is impossible to avoid noise due to the rapid industrialization of society. Continuous exposure to noise stress creates a disturbance in brain function which may lead to memory disorder. Therefore, it is necessary to find preventive measures to reduce the deleterious effects of noise exposure. Supplementation of taurine, a semi essential amino acid, is reported to alleviate psychiatric disorders. In this study noise-exposed (100 db; 3 h daily for 15 days) rats were supplemented with taurine at a dose of 100 mg/kg for 15 days. Spatial and recognition memory was assessed using the Morris water maze and novel object recognition task, respectively. Results of this study showed a reversal of noise-induced memory impairment in rats. The derangements of catecholaminergic and serotonergic levels in the hippocampus and altered brain antioxidant enzyme activity due to noise exposure were also restored by taurine administration. This study highlights the importance of taurine supplementation to mitigate noise-induced impaired memory via normalizing the neurochemical functions and reducing oxidative stress in rat brain.


Asunto(s)
Trastornos de la Memoria/tratamiento farmacológico , Fármacos Neuroprotectores/uso terapéutico , Ruido/efectos adversos , Estrés Oxidativo/efectos de los fármacos , Memoria Espacial/efectos de los fármacos , Taurina/farmacología , Animales , Masculino , Prueba del Laberinto Acuático de Morris/efectos de los fármacos , Prueba de Campo Abierto/efectos de los fármacos , Ratas Wistar , Reconocimiento en Psicología/efectos de los fármacos
2.
Sci Rep ; 10(1): 11206, 2020 07 08.
Artículo en Inglés | MEDLINE | ID: mdl-32641780

RESUMEN

Glutamate (Glu), the key excitatory neurotransmitter in the central nervous system, is considered essential for brain functioning and has a vital role in learning and memory formation. Earlier it was considered as a harmful agent but later found to be useful for many body functions. However, studies regarding the effects of free L-Glu administration on CNS function are limited. Therefore, current experiment is aimed to monitor the neurobiological effects of free L-Glu in male rats. L-Glu was orally administered to rats for 5-weeks and changes in behavioral performance were monitored. Thereafter, brain and hippocampus were collected for oxidative and neurochemical analysis. Results showed that chronic supplementation of free L-Glu enhanced locomotor performance and cognitive function of animals which may be attributed to the improved antioxidant status and cholinergic, monoaminergic and glutamatergic neurotransmission in brain and hippocampus. Current results showed that chronic supplementation of L-Glu affects the animal behaviour and brain functioning via improving the neurochemical and redox system of brain. Free L-Glu could be a useful therapeutic agent to combat neurological disturbances however this requires further targeted studies.


Asunto(s)
Química Encefálica/efectos de los fármacos , Ácido Glutámico/administración & dosificación , Hipocampo/efectos de los fármacos , Locomoción/efectos de los fármacos , Memoria/efectos de los fármacos , Administración Oral , Animales , Conducta Animal , Química Encefálica/fisiología , Suplementos Dietéticos , Ácido Glutámico/análisis , Ácido Glutámico/metabolismo , Hipocampo/química , Hipocampo/fisiología , Locomoción/fisiología , Masculino , Memoria/fisiología , Modelos Animales , Oxidación-Reducción/efectos de los fármacos , Ratas , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/fisiología , Ácido gamma-Aminobutírico/análisis , Ácido gamma-Aminobutírico/metabolismo
3.
Metab Brain Dis ; 35(7): 1189-1200, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32529399

RESUMEN

Pistachio contains polyphenolic compounds including flavonoids and anthocyanins which have antioxidant and antiinflammatory activity. Present study was aimed to evaluate the protective effects of pistachio on neurobehavioral and neurochemical changes in rats with Parkinson's disease (PD). Animal model of PD was induced by the injection of rotenone (1.5 mg/kg/day, s.c.) for 8 days. Pistachio (800 mg/kg/day, p.o.) was given for two weeks in both pre- and post-treatment. At the end of treatment brain was dissected out and striatum was isolated for biochemical and neurochemical analysis. Memory was assessed by Morris water maze (MWM) and novel object recognition (NOR) test while open field test (OFT), Kondziela inverted screen test (KIST), pole test (PT), beam walking test (BWT), inclined plane test (IPT) and footprint (FP) test were used to observe motor behavior. Rotenone administration significantly (p < 0.01) impaired the memory but pistachio in both pre- and post-treatment groups significantly (p < 0.01) improved memory performance. Rotenone-induced motor deficits were significantly attenuated in both pre- and post-pistachio treatment. Increased oxidative stress and decreased DA and 5-HT levels induced by rotenone were also significantly attenuated by pistachio supplementation. Furthermore, raised apolipoprotein E (APoE) levels in rotenone injected rats were also normalized following treatment with pistachio. Present findings show that pistachio possesses neuroprotective effects and improves memory and motor deficits via increasing DA levels and improving oxidative status in brain.


Asunto(s)
Apolipoproteínas E/metabolismo , Cuerpo Estriado/efectos de los fármacos , Destreza Motora/efectos de los fármacos , Fármacos Neuroprotectores/uso terapéutico , Enfermedad de Parkinson Secundaria/tratamiento farmacológico , Pistacia , Extractos Vegetales/uso terapéutico , Animales , Cuerpo Estriado/metabolismo , Modelos Animales de Enfermedad , Fármacos Neuroprotectores/farmacología , Estrés Oxidativo/efectos de los fármacos , Enfermedad de Parkinson Secundaria/inducido químicamente , Enfermedad de Parkinson Secundaria/metabolismo , Extractos Vegetales/farmacología , Ratas , Rotenona
4.
Pak J Pharm Sci ; 32(1(Supplementary)): 277-283, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30829204

RESUMEN

Magnesium (Mg) is an essential biomineral that acts as an intracellular cofactor for more than 300 enzymes. It is an important modulator of the N-methyl-D-aspartate (NMDA) receptor which is involved in memory function and depression. The purpose of this study was to compare the dose dependent effect of oral supplementation of Magnesium chloride (MgCl2), Magnesium sulphate (MgSO4) and Magnesium-L-threonate (MgT) on memory and depression-related behaviors in rats. Rats were orally administered with different doses (50 mg/kg, 100 mg/kg and 150 mg/kg) of each Mg salt. Following 28 days of oral supplementation, animals were subjected to behavioral tests. After completion of behavioral test, rats were decapitated. Brain and plasma samples were used for neurochemical and biochemical analysis. Assessment of behaviors in elevated plus maze (EPM) test and forced swim test (FST) showed that MgT more significantly improved memory of rats and decreased depression-like symptoms in healthy rats as compared to controls. Biochemical analysis indicated significant increase in plasma Mg levels dose dependently following MgT administration. This increase might be related to observe enhanced cholinergic functions and decline in oxidative stress in rats in the present study. This comparative study highlights that MgT (100mg/kg) is the most appropriate Mg salt and dose for oral treatment that strengthens cholinergic system and improves brain related functions through attenuation of oxidative burden in adult healthy rats.


Asunto(s)
Encéfalo/efectos de los fármacos , Butiratos/farmacología , Cloruro de Magnesio/farmacología , Sulfato de Magnesio/farmacología , Memoria/efectos de los fármacos , Acetilcolina/metabolismo , Animales , Conducta Animal/efectos de los fármacos , Encéfalo/metabolismo , Butiratos/administración & dosificación , Depresión/tratamiento farmacológico , Relación Dosis-Respuesta a Droga , Magnesio/sangre , Cloruro de Magnesio/administración & dosificación , Sulfato de Magnesio/administración & dosificación , Masculino , Ratas Wistar
5.
Pharmacol Biochem Behav ; 159: 90-99, 2017 08.
Artículo en Inglés | MEDLINE | ID: mdl-28642069

RESUMEN

Choline, an essential nutrient, accounts for multiple functions in the body and brain. While its beneficial effects on healthy adults are not clear, choline supplementation is important during pregnancy for brain development, in elderly patients for support of cognitive performance and in patients with neurological disorders to reduce memory deficits. Thus, the aim of this study is to investigate whether choline administration in healthy adult rats beneficially impacts cognitive and locomotor performance, and associated oxidative and neurochemical outcomes. Two groups, control and choline, received tap water and choline bitartrate, respectively at the dose equivalent to adequate intake for five weeks. Food intake and body weight were monitored daily. Behavioral analysis comprising assessment of cognitive performance (by novel object recognition, passive avoidance and Morris Water Maze test) and locomotor performance (by Open field, Kondziela's inverted screen and beam walking test) were performed. Following testing, rats were decapitated and brain samples were collected for estimation of acetylcholine, redox profile and monoamine measurements. The results showed that chronic choline administration significantly improves cognitive and locomotor performance accompanied by a reduction in oxidative stress, enhanced cholinergic neurotransmission and monoamine levels in the brain of healthy adult rats. Hence, chronic choline intake was found to improve behavioral, oxidative and neurochemical outcomes in the normal population, so it can be suggested that choline tablets can be used as a safe and effective supplement for improving the neurological health of normal individuals and that they might also be beneficial in preventing cognitive and motor disorders later in life.


Asunto(s)
Antioxidantes/farmacología , Química Encefálica/efectos de los fármacos , Colina/farmacología , Cognición/efectos de los fármacos , Nootrópicos/farmacología , Estrés Oxidativo/efectos de los fármacos , Desempeño Psicomotor/efectos de los fármacos , Acetilcolina/metabolismo , Animales , Reacción de Prevención/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Suplementos Dietéticos , Ingestión de Alimentos/efectos de los fármacos , Aprendizaje por Laberinto/efectos de los fármacos , Ratas , Ratas Wistar
6.
Pak J Pharm Sci ; 30(3(Suppl.)): 1013-1021, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28655701

RESUMEN

Glutamate (GLU) and gamma-amino butyric acid (GABA) are essential amino acids (AA) for brain function serving as excitatory and inhibitory neurotransmitter respectively. Their tablets are available in market for improving gut function and muscle performance. Despite of having a major role during memory formation and processing, effects of these tablets on brain functioning like learning and memory have not been investigated. Therefore, present study is aimed to investigate the effects of orally supplemented GLU and GABA on learning and memory performance and further to monitor related effects of these orally supplemented GLU and GABA on brain levels of these AA. Three groups of rats were supplemented orally with drinking water (control group) or suspension of tablets of GABA and Glutamate, respectively for four weeks. Cognitive performance was determined using behavioral tests (Novel object recognition test, Morris water maze, Passive avoidance test) measuring recognition, spatial reference and aversive memory. Levels of GLU, GABA and acetylcholine (ACh) were estimated in rat hippocampus. Results showed that chronic oral administration of GLU and GABA tablets has a significant impact on brain function and can alter GLU and GABA content in rat hippocampus. Compared to GABA, GLU supplementation specifically enhances memory performance via increasing ACh. Thus, GLU can be suggested as a useful supplement for improving learning and memory performance and neurochemical status of brain and in future could be effective in the treatment of neurological disorders affecting learning and memory performance.


Asunto(s)
Química Encefálica/efectos de los fármacos , Ácido Glutámico/farmacología , Hipocampo/efectos de los fármacos , Memoria/efectos de los fármacos , Ácido gamma-Aminobutírico/farmacología , Acetilcolina/metabolismo , Animales , Cognición/efectos de los fármacos , Suplementos Dietéticos , Relación Dosis-Respuesta a Droga , Ácido Glutámico/administración & dosificación , Ácido Glutámico/farmacocinética , Hipocampo/química , Hipocampo/metabolismo , Aprendizaje por Laberinto/efectos de los fármacos , Ratas Wistar , Factores de Tiempo , Ácido gamma-Aminobutírico/administración & dosificación , Ácido gamma-Aminobutírico/farmacocinética
7.
Brain Res Bull ; 120: 63-74, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26548495

RESUMEN

Dietary nutrients may play a vital role in protecting the brain from age-related memory dysfunction and neurodegenerative diseases. Tree nuts including almonds have shown potential to combat age-associated brain dysfunction. These nuts are an important source of essential nutrients, such as tocopherol, folate, mono- and poly-unsaturated fatty acids, and polyphenols. These components have shown promise as possible dietary supplements to prevent or delay the onset of age-associated cognitive dysfunction. This study investigated possible protective potential of almond against scopolamine induced amnesia in rats. The present study also investigated a role of acetylcholine in almond induced memory enhancement. Rats in test group were orally administrated with almond suspension (400 mg/kg/day) for four weeks. Both control and almond-treated rats were then divided into saline and scopolamine injected groups. Rats in the scopolamine group were injected with scopolamine (0.5 mg/kg) five minutes before the start of each memory test. Memory was assessed by elevated plus maze (EPM), Morris water maze (MWM) and novel object recognition (NOR) task. Cholinergic function was determined in terms of hippocampal and frontal cortical acetylcholine content and acetylcholinesterase activity. Results of the present study suggest that almond administration for 28 days significantly improved memory retention. This memory enhancing effect of almond was also observed in scopolamine induced amnesia model. Present study also suggests a role of acetylcholine in the attenuation of scopolamine induced amnesia by almond.


Asunto(s)
Trastornos de la Memoria/dietoterapia , Prunus dulcis , Acetilcolina/metabolismo , Acetilcolinesterasa/metabolismo , Animales , Modelos Animales de Enfermedad , Lóbulo Frontal/metabolismo , Hipocampo/metabolismo , Aprendizaje por Laberinto , Trastornos de la Memoria/metabolismo , Distribución Aleatoria , Ratas Wistar , Reconocimiento en Psicología , Escopolamina , Resultado del Tratamiento
8.
Life Sci ; 124: 110-9, 2015 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-25637686

RESUMEN

AIMS: D-Galactose (D-gal) induced accelerated senescence has been used to develop an aging model for brain. Previously, long term administration of a wide range of doses has been used for this purpose. In the present study we investigate whether short term administration of a high dose of D-gal in rats induces significant signs and symptoms similar to natural aging. MAIN METHODS: Young rats were injected intraperitoneally with D-gal at a dose of 300 mg/ml/kg for one week. Behavioral analysis for depression and anxiety like symptoms were monitored by forced swim test (FST) and light/dark transition (LDT) test. Assessment of memory was done using the Morris water maze (MWM), passive avoidance test (PAT) and elevated plus maze (EPM) test. Biochemical analysis was done for estimation of antioxidant enzymes and acetylcholinesterase. Determination of brain biogenic amines was performed by HPLC-EC. KEY FINDINGS: Short term administration of D-gal significantly altered behavioral, biochemical and neurochemical responses in rats. D-Gal injected rats exhibited depressogenic and anxiogenic behaviors while memory was also significantly impaired in these rats. Brain lipid peroxidation and superoxide dismutase activity were significantly increased while catalase and glutathione peroxidase decreased. Increased activity of acetylcholinesterase was also exhibited by D-gal injected rats while brain biogenic amines were significantly decreased. Food intake and growth rate were however comparable in both groups. SIGNIFICANCE: Together the behavioral, biochemical and neurochemical impairments following the high dose of D-gal suggest that symptoms similar to natural aging may be developed in rats in as early as one week.


Asunto(s)
Envejecimiento/fisiología , Conducta Animal/fisiología , Encéfalo/fisiología , Galactosa/farmacología , Memoria/fisiología , Acetilcolinesterasa/metabolismo , Animales , Antioxidantes/metabolismo , Aminas Biogénicas/metabolismo , Catalasa/metabolismo , Cromatografía Líquida de Alta Presión , Relación Dosis-Respuesta a Droga , Galactosa/administración & dosificación , Glutatión Peroxidasa/metabolismo , Peroxidación de Lípido/fisiología , Masculino , Aprendizaje por Laberinto , Ratas , Ratas Wistar , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA